VANESSA LEHNER: Open Payments
NPI 1467698902 · ROCKLEDGE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$276 in 14 payments from 8 companies in 2025. Trend: 2023 $267 · 2024 $92 · 2025 $276
Food & beverage: $276
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $67 |
| Amgen Inc. | 3 | $52 |
| Novo Nordisk Inc | 2 | $44 |
| AstraZeneca Pharmaceuticals LP | 2 | $39 |
| Vanda Pharmaceuticals Inc. | 1 | $26 |
| Alkermes, Inc. | 1 | $16 |
| Abbott Laboratories | 1 | $16 |
| ABBVIE INC. | 1 | $15 |
Products named: XIFAXAN, BREZTRI, OTEZLA, FANAPT, Rybelsus, Ozempic, REPATHA, VIVITROL.
Industry payments across FL — which companies pay providers there.
